Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCLETIS-B

11.870
-0.050-0.42%
Volume:3.28M
Turnover:38.38M
Market Cap:11.44B
PE:-36.16
High:12.200
Open:12.200
Low:11.430
Close:11.920
Loading ...

Ascletis Pharma Completes Enrollment in Obesity Drug Study in the US

MT Newswires Live
·
05 Aug

HK Movers | Biotech Stocks Extend Rally. Junshi Bio up over 24%; Genor up 23%; Ascletis up 15%; Ascentage up 13%; Dualitybio up 12%

Tiger Newspress
·
05 Aug

Ascletis Announces First Participants With Obesity or Overweight Dosed in Its U.S. 12-Week Phase Iia Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule Glp-1R Agonist Asc30

THOMSON REUTERS
·
28 Jul

Ascletis Pharma Inc. Announces Initiation of U.S. Phase IIA Study for Once-Monthly Subcutaneous GLP-1R Agonist ASC30 for Obesity Treatment

Reuters
·
28 Jul

HK Movers | HK's Biotech Shares Soar. Fudan-zhangjiang Soars 22%; Akeso up 11%; CStone Pharma up 9%

Tiger Newspress
·
17 Jul

Ascletis Pharma Completes Dosing in U.S. Clinical Trial for Obesity Treatment Combining ASC47 and Semaglutide

Reuters
·
15 Jul

This Ascletis Pharma Insider Increased Their Holding In The Last Year

Simply Wall St.
·
14 Jul

HK Movers | Pharma Stocks Shine. Luye Pharma up 8%; Hua Medicine, Hengrui Pharma up 7%; Sino Biopharm, Fudan Zhangjiang up over 3%

Tiger Newspress
·
09 Jul

HK Movers|Biotech Stocks Gained. RemeGen, Junshi Bio And TigerMed Up 3%; Laekna And JW Therap Up 1%

Tiger Newspress
·
08 Jul

HK Movers|HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%

Tiger Newspress
·
03 Jul

Ascletis Pharma Inc. Announces Dosing of First Participants in U.S. Phase IIa Study of Oral GLP-1R Agonist ASC30 for Obesity Treatment

Reuters
·
03 Jul

Ascletis Pharma Faces Third-Party Challenge Over U.S. Patent Validity in Post Grant Review

Reuters
·
30 Jun

Ascletis Pharma Inc. Announces First Participants Dosed in U.S. Phase I Clinical Trial of Potential Best-in-Class Psoriasis Treatment ASC50

Reuters
·
18 Jun

HK Movers | HK's Biotech Shares Soar. JOINN Soars 8%; Fudan-Zhangjiang up 6%; HeartCare up 2%

Tiger Newspress
·
17 Jun

HK Movers | Biotech Stocks Jump. Canbridge Soars 40%; Ascletis Jumps 17%; TYK Medicines Gains 7%; HBM Holdings, Abbisko Up More Than 6%

Tiger Newspress
·
16 Jun

China's Biotech Moment Ignites a 60% Stock Rally That Beats AI

Bloomberg
·
15 Jun

HK Movers|Pharma Shares Rallied. Sino Biopharm Up 13%; Immunothech And Zai Lab Up 5%; Dualitybio And Grand Pharmaup 4%

Tiger Newspress
·
12 Jun

Ascletis Pharma Inc. Announces Poster Presentations on Study Results of GLP-1R Agonist ASC30 and Weight Loss Drug Candidate ASC47 at ADA Scientific Sessions

Reuters
·
09 Jun

HK Movers|Pharma Shares Rallied. CSPC Pharma Up 9%; 3SBio Up 4%; Yihai Up 3%; Genscript Bio And JXR Up 2%.

Tiger Newspress
·
06 Jun

HK Movers|HK Pharma Shares Kept Rally. Zai Lab Up 7%; Hutchmed Up 6%; Immunotech Up 5%

Tiger Newspress
·
05 Jun